TimeScale Financial’s Moderna MRNA Stock Holding History

TimeScale Financial’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$742K	Hold	6,108	–	–	0.16%	35
2023 Q1	$938K	Hold	6,108	–	–	0.21%	29
2022 Q4	$722K	Hold	6,108	–	–	0.21%	17
2022 Q3	$722K	Hold	6,108	–	–	0.21%	17
2022 Q2	$873K	Hold	6,108	–	–	0.24%	17
2022 Q1	$1.05M	Sell	6,108 -18	-0.3%	-$3.03K	0.25%	17
2021 Q4	$1.56M	Buy	6,126 +6,067	+10,283%	+$1.77M	0.35%	13
2021 Q3	$23K	Hold	59	–	–	0.01%	232
2021 Q2	$14K	Hold	59	–	–	﹤0.01%	279
2021 Q1	$8K	Buy	59 +6	+11%	+$869	﹤0.01%	343
2020 Q4	$6K	Buy	53 +10	+23%	+$1.01K	﹤0.01%	323
2020 Q3	$3K	Buy	43 +18	+72%	+$1.25K	﹤0.01%	389
2020 Q2	$1K	Hold	25	–	–	﹤0.01%	418
2020 Q1	$0	Hold	25	–	–	﹤0.01%	488
2019 Q4	$0	Hold	25	–	–	﹤0.01%	532
2019 Q3	$0	Hold	25	–	–	﹤0.01%	525
2019 Q2	$0	Buy	+25	New	+$537	﹤0.01%	521

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TimeScale Financial's MRNA Position: Q2 2023 in Review

TimeScale Financial held its Moderna (MRNA) position steady in Q2 2023 at 6,108 shares worth $742K. The position accounts for 0.16% of the portfolio, ranked #35.

TimeScale Financial first reported a position in MRNA in Q2 2019 and has held it in 17 quarters since. The position peaked at $1.56M in Q4 2021. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.

TimeScale Financial held 6,108 shares of Moderna worth $742K as of Q2 2023.
TimeScale Financial left its Moderna share count unchanged in Q2 2023.
Moderna made up 0.16% of TimeScale Financial's portfolio in Q2 2023, its #35 holding.
TimeScale Financial first reported a position in Moderna in Q2 2019 and has held it in 17 quarters since.
TimeScale Financial's Moderna position peaked at $1.56M in Q4 2021.
965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.

Based on TimeScale Financial's 13F filing for Q2 2023, filed 27 Jul 2023.